'Like Water': Pharma Avoids Much Scrutiny In Messy Presidential Debate
Executive Summary
Trump and Biden trade barbs in debate that included a suggestion by the president that coronavirus vaccine development delays are political and saw Biden questioned on whether he was contributing to vaccine hesitancy.
You may also be interested in...
VP Debate: Pence Tries Vaccine Hesitancy Jujutsu On Harris
‘Senator, please stop undermining confidence in a vaccine,’ Pence says when confronted with the accusation that the administration is politicizing the COVID vaccine development effort.
Coronavirus Update: Trump Tests Positive, US Pause Remains On AstraZeneca Vaccine
Meanwhile, seven former US FDA commissioners issue joint plea for trust in the scientific integrity of the agency.
Pharma Catches A Break As Democrats Stumble In Rollout Of Pricing Investigation
House Oversight Committee plans to grill more companies on pricing later this year, but rushed rollout of reports from a long-running investigation, combined with competing higher profile news events, seemed to dampen the blow of the latest drug pricing scrutiny. Democrats failed to offer any new, unified solutions for their grievances with industry, while Republicans largely rushed to pharma’s defense.